•
Dec 31, 2023
HCA Q4 2023 Earnings Report
HCA Healthcare's financial performance was solid in Q4 2023, driven by strong demand for services and improved cost trends.
Key Takeaways
HCA Healthcare reported revenues of $17.303 billion and net income of $1.607 billion for the fourth quarter of 2023. The company experienced strong demand for services and improved cost trends, contributing to the positive financial results.
Revenues totaled $17.303 billion.
Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share.
Adjusted EBITDA totaled $3.618 billion.
Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent.
HCA
HCA
Forward Guidance
The Company issued the following estimated guidance for 2024:
Positive Outlook
- Revenues $67.75 to $70.25 billion
- Net Income Attributable to HCA Healthcare, Inc. $5.20 to $5.60 billion
- Adjusted EBITDA $12.85 to $13.55 billion
- EPS (diluted) $19.70 to $21.20 per diluted share
- Capital expenditures for 2024, excluding acquisitions, are estimated to be in the range of $5.1 to $5.3 billion.
Challenges Ahead
- The Company’s 2024 guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding patient volumes and payor mix as well as general economic conditions, including inflation, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.
- The Company’s guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.”
- Changes in revenues due to declining patient volumes
- Changes in payer mix (including increases in uninsured and underinsured patients)
- Potential increased expenses related to labor, supply chain or other expenditures